CG Oncology (CGON) Receivables - Net (2023 - 2025)
CG Oncology (CGON) has disclosed Receivables - Net for 3 consecutive years, with $688000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net changed N/A year-over-year to $688000.0, compared with a TTM value of $688000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $688000.0, changed N/A over the prior year.
- Receivables - Net was $688000.0 for Q4 2025 at CG Oncology, up from $515000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $688000.0 in Q4 2025 and bottomed at $92000.0 in Q4 2023.
- Average Receivables - Net over 3 years is $334250.0, with a median of $263500.0 recorded in 2024.
- Peak annual rise in Receivables - Net hit 275.91% in 2025, while the deepest fall reached 125.49% in 2025.
- Year by year, Receivables - Net stood at $92000.0 in 2023, then soared by 48.91% to $137000.0 in 2024, then skyrocketed by 402.19% to $688000.0 in 2025.
- Business Quant data shows Receivables - Net for CGON at $688000.0 in Q4 2025, $515000.0 in Q3 2025, and $562000.0 in Q2 2025.